Oscar Health, Inc. Class A (OSCR) earnings
OSCR earnings moved a median of +1.48% by the close. Quarterly and annual OSCR reports and results, each read against the price at its own news timestamp. Back to the OSCR overview →
29 measured OSCR earnings events.
Where these OSCR earnings landedvs 29 measured OSCR earnings reactions
| Middle 50% of OSCR earnings reactions | -2.18% to +5.52% |
|---|---|
| Median reaction (to close) | +1.48% |
| Measured reactions | 29 |
Point-in-time · zero look-ahead
Half of the 29 OSCR earnings events with a measured close landed between -2.18% and +5.52%; 55% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Oscar Health, Inc. 2026 Third Quarter Earnings Conference Call | Press release | -1.10% | +0.92% | |
| Form 10-Q Oscar Health, Inc. For: Jun 30 | SEC filing · Form 10-Q | -1.08% | +5.52% | |
| Oscar Health, Inc. 2026 Second Quarter Earnings Conference Call | Press release | -0.36% | +2.20% | |
| Form 10-Q Oscar Health, Inc. For: Mar 31 | SEC filing · Form 10-Q | -1.43% | +1.48% | |
| Oscar Health Announces Strong Financial Results for First Quarter 2026 And Reaffirms 2026 Guidance | Press release | +1.68% | +5.31% | |
| Oscar Health, Inc. 2026 First Quarter Earnings Conference Call | Press release | +0.88% | -0.31% | |
| Form 10-K Oscar Health, Inc. For: Dec 31 | SEC filing · Form 10-K | +1.98% | +1.98% | |
| Oscar Health, Inc. 2025 Fourth Quarter and Full Year Earnings Conference Call | Press release | -1.06% | -3.28% | |
| Form 10-Q Oscar Health, Inc. For: Sep 30 | SEC filing · Form 10-Q | +0.03% | +7.92% | |
| Oscar Health Announces Financial Results for Third Quarter 2025 and Reaffirms 2025 Guidance | Press release | +2.50% | -10.44% | |
| Oscar Health, Inc. 2025 Third Quarter Earnings Conference Call | Press release | -1.68% | -4.30% | |
| Form 10-Q Oscar Health, Inc. For: Jun 30 | SEC filing · Form 10-Q | -0.61% | +1.98% | |
| Oscar Health Announces Financial Results for Second Quarter 2025 and Reaffirms Updated 2025 Guidance | Press release | +7.04% | +8.64% | |
| Oscar Health Announces Preliminary Financial Results for Second Quarter 2025 and Revises 2025 Guidance | Press release | +4.17% | +13.51% | |
| Form 10-Q Oscar Health, Inc. For: Mar 31 | SEC filing · Form 10-Q | +2.34% | -2.51% | |
| Oscar Health Announces Strong Financial Results for First Quarter 2025 And Reaffirms 2025 Guidance | Press release | -0.19% | +8.13% | |
| Oscar Health, Inc. 2025 First Quarter Earnings Conference Call | Press release | +1.47% | +8.12% | |
| Form 10-K Oscar Health, Inc. For: Dec 31 | SEC filing · Form 10-K | -1.78% | -10.45% | |
| Oscar Health, Inc. 2024 Fourth Quarter and Full Year Earnings Conference Call | Press release | +0.33% | -5.40% | |
| Form 10-Q Oscar Health, Inc. For: Sep 30 | SEC filing · Form 10-Q | +2.35% | -0.51% | |
| Oscar Health Announces Results for Third Quarter 2024 | Press release | -3.30% | -4.35% | |
| Form 10-Q Oscar Health, Inc. For: Jun 30 | SEC filing · Form 10-Q | -0.13% | +8.58% | |
| Oscar Health Announces Results for Second Quarter 2024 and Raises Full Year Revenue and Adjusted EBITDA Outlook | Press release | -2.45% | -0.06% | |
| Form 10-Q Oscar Health, Inc. For: Mar 31 | SEC filing · Form 10-Q | -2.19% | +5.49% | |
| Oscar Health Announces Results for First Quarter 2024 | Press release | -4.75% | -2.18% | |
| Form 10-K Oscar Health, Inc. For: Dec 31 | SEC filing · Form 10-K | -0.45% | -1.17% | |
| Oscar Health, Inc. 2023 Fourth Quarter and Full Year Earnings Conference Call | Press release | -1.87% | -1.69% | |
| Form 10-Q Oscar Health, Inc. For: Sep 30 | SEC filing · Form 10-Q | +3.52% | +3.37% | |
| Oscar Health Announces Results for Third Quarter 2023 and Raises Full Year 2023 Adjusted EBITDA Outlook; New +Oscar Agreement | Press release | +2.08% | +5.92% |
Keep exploring
More OSCR: analyst actions → · SEC filings → · OSCR overview →